Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

YouScript IMPACT (Improving Medication Protocols and Abating Cost of Treatment) Registry

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02191358
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:16.776029+00:00
Published At
2017-03-01T00:00:00+00:00
Record Updated At
2017-03-01
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adverse Drug Events", "Adverse Drug Reactions", "Drug Interaction Potentiation", "Drug Metabolism, Poor, CYP2D6-RELATED", "Drug Metabolism, Poor, CYP2C19-RELATED", "Cytochrome P450 Enzyme Deficiency", "Cytochrome P450 CYP2D6 Enzyme Deficiency", "Cytochrome P450 CYP2C9 Enzyme Deficiency", "Cytochrome P450 CYP2C19 Enzyme Deficiency", "Cytochrome P450 CYP3A Enzyme Deficiency", "Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant", "Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant", "Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-03-01"
protocolSection.identificationModule.nctId
"NCT02191358"
protocolSection.identificationModule.officialTitle
"YouScript IMPACT (Improving Medication Protocols and Abating Cost of Treatment) Registry"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Adverse Drug Events (protocolSection.conditionsModule.conditions)
  • Adverse Drug Reactions (protocolSection.conditionsModule.conditions)
  • Drug Interaction Potentiation (protocolSection.conditionsModule.conditions)
  • Drug Metabolism, Poor, CYP2D6-RELATED (protocolSection.conditionsModule.conditions)
  • Drug Metabolism, Poor, CYP2C19-RELATED (protocolSection.conditionsModule.conditions)
  • Cytochrome P450 Enzyme Deficiency (protocolSection.conditionsModule.conditions)
  • Cytochrome P450 CYP2D6 Enzyme Deficiency (protocolSection.conditionsModule.conditions)
  • Cytochrome P450 CYP2C9 Enzyme Deficiency (protocolSection.conditionsModule.conditions)
  • Cytochrome P450 CYP2C19 Enzyme Deficiency (protocolSection.conditionsModule.conditions)
  • Cytochrome P450 CYP3A Enzyme Deficiency (protocolSection.conditionsModule.conditions)
  • Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant (protocolSection.conditionsModule.conditions)
  • Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant (protocolSection.conditionsModule.conditions)
  • Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.